Drugs / Danzhen
last change Jul 2017 re-read 2 minutes ago

Danzhen

Developed for
migraine disorder
Investigated by
Ecion Pharmaceutical CO..LTD · Xijing Hospital

Trials 1 · a red edge is where a trial was stopped

20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT02645370 Feb 2016 → Jul 2017 migraine disorder Xijing Hospital Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Danzhen ClinicalTrials.gov intervention name — accepted as the source's own label NCT02645370